CN1065132C - Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc - Google Patents

Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc Download PDF

Info

Publication number
CN1065132C
CN1065132C CN97101173A CN97101173A CN1065132C CN 1065132 C CN1065132 C CN 1065132C CN 97101173 A CN97101173 A CN 97101173A CN 97101173 A CN97101173 A CN 97101173A CN 1065132 C CN1065132 C CN 1065132C
Authority
CN
China
Prior art keywords
intervertebral disc
prolapse
lumbar intervertebral
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97101173A
Other languages
Chinese (zh)
Other versions
CN1192911A (en
Inventor
崔庆杰
于亚涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97101173A priority Critical patent/CN1065132C/en
Publication of CN1192911A publication Critical patent/CN1192911A/en
Application granted granted Critical
Publication of CN1065132C publication Critical patent/CN1065132C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc. The medicine is prepared from red ginseng, notoginseng, safflower, earth worm, musk, dragon blood, myrrh and olibanum. Clinic use indicates that the curative effect of the medicine is superior to the existing various Chinese patent medicines for treating prolapse of lumbar intervertebral disc. The total effective rate reaches 98%, and the cure rate reaches 78%. The medicine has the efficiency for supplementing qi and activating blood circulation, expelling wind and clearing away cold, regulating channels and promoting the recovery of the protruded intervertebral disc, and is suitable for symptoms of the prolapse of lumbar intervertebral disc caused by various reasons.

Description

The Chinese medicine preparation of treatment prolapse of lumbar intervertebral disc
The present invention relates to a kind of Chinese medicine preparation for the treatment of prolapse of lumbar intervertebral disc.
Prolapse of lumbar intervertebral disc is clinical common frdquently encountered disease, the existing more consistent understanding of Chinese scholars is first-selected non-operative treatment, promptly lie up, massage, physical therapy, traction, Chinese medicine and trophic nerve medicine etc., over nearly 20~30 years, adopt both at home and abroad and in the vertebra dish, inject lytic agent, effective percentage is about 70%, the attached SHUGUANG HOSPITAL of Shanghai Medical Univ, hospitals such as Xuchang, Henan adopt the easypro waist soup (Shandong journal of Chinese medicine 95.5.213P) of Pheretima, three worm SIWU TANG (Henan Journal of Traditional Chinese Medicine 94.6.345P), Radix Angelicae Pubescentis et Herba Taxilli Decoction (Zhejiang Journal of Traditional Chinese Medicine 94.2.67P) oral medication, 88.8%~96.43%, cure rate is between 37.5~61.3% with above-mentioned decoction treatment total effective rate.Carry inconvenience but exist to take, strong to the selectivity of distinguishing the disease classification therapy, defective such as cure rate is lower; Application compound recipe Semen Strychni powder (journal of shanghai Chinese medicine 1986.4.26P) oral medication total effective rates such as Wang Zhiwen are 96%, cure rate 55%, Tianjin Hospital of air force orthopaedics adopts " Young discutient and analgesic plaster " (Jiangsu traditional Chinese medical science 94.2.67P), application treatment, total effective rate 96.3%, cure rate 43%, curative effect are still undesirable; Solve the 208th hospital of army and adopt the red moxibustion of Moschus to control (combination of Chinese and Western medicine magazine 93.11.692P) cure rate 72.89%, total effective rate 98.8%, though the more above-mentioned decoction of curative effect, powder are good, clinical trouble, the patient can not use treatment alone.So far, do not see curative effect ideal, taking convenience as yet both at home and abroad, can be suitable for the relevant report of the prominent disease patient's of various disease type waists Chinese medicine preparation.
The objective of the invention is to overcome the various defectives that existing medicine exists in using and treating, the innerwear Chinese medicine preparation of the prominent disease of a kind of safe and efficient treatment waist is provided, this medicine has benefiting QI for activating blood circulation, expelling wind and cold, logical regulating menstruation arteries and veins, the effect of impelling outstanding intercalated disc also to receive is suitable for the prolapse of lumbar intervertebral disc that a variety of causes causes.
The present invention is achieved in that selecting Chinese medicine Radix Ginseng Rubra, Radix Notoginseng, Flos Carthami, eupolyphage sece steleophaga, Moschus, Sanguis Draxonis, Myrrha, Olibanum for use is that preparation of raw material forms, and proportioning raw materials is (weight):
Radix Ginseng Rubra 50~70g Radix Notoginseng 25~35g
Flos Carthami 260~340g eupolyphage sece steleophaga 15~25g
Moschus 1.5~2.5g Sanguis Draxonis 5~10g
Myrrha 130~170g Olibanum 130~170g
Preparation method of the present invention is: Radix Ginseng Rubra, Olibanum, Myrrha, Flos Carthami, eupolyphage sece steleophaga, the Sanguis Draxonis powder with said ratio is broken into 80~100 order fine powders earlier, with the Radix Notoginseng powder mixing for standby use of above-mentioned amount; Be dissolved in 95% the alcoholic solution standby after again the Moschus of above-mentioned amount being ground; Get refined honey and medicated powder and medicine, proportioning is a medicated powder: the honey temperature control stirs medicated powder and refined honey at 70~80 ℃ when refined honey=1: 1 (weight ratio) and medicine, becomes to moisten bulk; Again above-mentioned musk alcohol solution is blended among the agglomerate last and even, pill.Medicine according to said ratio also can be made into dosage forms such as tablet, capsule.
The present invention compares with the Chinese and western drugs of the prominent disease of existing treatment waist has following advantage:
1, comprehensive therapeutic effect is good, by total effective rate 98% is added up in 100 routine case clinical observations, cure rate 78% selects for use the curative effect red moxibustion of Moschus preferably to control in contrast matched group total effective rate 96% simultaneously, 74%, two group of curative effect significant difference of cure rate (p<0.01);
2, medicine of the present invention has benefiting QI for activating blood circulation, the effect of expelling wind and cold, removing damp-heat, the pulse-taking that stimulates the menstrual flow, reducing swelling and alleviating pain, be applicable to the prolapse of lumbar intervertebral disc that a variety of causes causes, treat different pattern of syndrome prolapse of lumbar intervertebral disc curative effects no significant difference (P>0.05) between various with the present invention;
3, use is easy to carry, observe through clinical use, and nontoxic, the side effect of this medicine, safe and effective.

Claims (1)

1, a kind of medicine for the treatment of prolapse of lumbar intervertebral disc is characterized in that its proportioning raw materials is:
Radix Ginseng Rubra 50~70g Radix Notoginseng 25~35g
Flos Carthami 260~340g eupolyphage sece steleophaga 15~25g
Moschus 1.5~2.5g Sanguis Draxonis 5~10g
Myrrha 130~170g Olibanum 130~170g.
CN97101173A 1997-03-07 1997-03-07 Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc Expired - Fee Related CN1065132C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97101173A CN1065132C (en) 1997-03-07 1997-03-07 Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97101173A CN1065132C (en) 1997-03-07 1997-03-07 Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc

Publications (2)

Publication Number Publication Date
CN1192911A CN1192911A (en) 1998-09-16
CN1065132C true CN1065132C (en) 2001-05-02

Family

ID=5165560

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97101173A Expired - Fee Related CN1065132C (en) 1997-03-07 1997-03-07 Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc

Country Status (1)

Country Link
CN (1) CN1065132C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101322794B (en) * 2008-07-28 2010-12-29 朱文 Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation

Also Published As

Publication number Publication date
CN1192911A (en) 1998-09-16

Similar Documents

Publication Publication Date Title
CN101632737A (en) Medicament for relieving pain of human body and preparation method thereof
CN101987123A (en) Medicament for easing pain of human body and preparation method thereof
CN101987122A (en) Medicament for easing pain of human body and preparation method thereof
CN102552517A (en) Gynecological sugar-free gynaecopathia treating particle and preparation method thereof
CN101485803B (en) Chinese medicinal composition for treating menoxenia and dysmenorrhea
CN102579610B (en) Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof
CN102727823B (en) Medicine for postoperative rehabilitation of cerebral hemorrhage
CN102205064B (en) Traditional Chinese medicine (TCM) for treating threatened abortion
CN101912563B (en) Medicament for treating constipation and preparation method thereof
CN102068650A (en) Chinese herbal medicine for treatment of dysmenorrhea
CN1065132C (en) Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc
CN1278707C (en) Fengtongning Chinese medicinal preparaton and its preparation method
CN100396300C (en) Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same
CN102038930A (en) Medicament for treating protrusion of lumbar vertebral disc
CN101897777A (en) Traditional Chinese herbal medicine for treating cervical headache
CN1286515C (en) Medicinal composition for treating cyst
CN1618439A (en) Broad-specturm medicine for treating snake venom poisoning
CN103977363A (en) Traditional Chinese medicine composition for treating hypertension
CN101085185A (en) Beverage containing white peony root and gardenia
CN101181441A (en) Medicine for treating premature ovarian failure and preparation process thereof
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN104666880A (en) Nursing medicine for treating postpartum hypogalactia
CN1352979A (en) Chinese medicine for replenishing vital energy and promoting blood circulation
CN101310755A (en) Medicine for promoting the quick cure of fracture and preparation method thereof
CN101912501B (en) Medicament for treating ormarthritis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee